newsfilter
← Latest News
PR Newswire·

Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that, as previously disclosed in its Annual Report on...